The Journal of Organic Chemistry
Article
SiO2−PPh3−AuNTf2 as brown nanoparticles. The gold content was
found to be 0.21 mmol g−1 by ICP-AES.
143.8, 140.8, 137.7, 128.4, 127.3, 126.9, 126.8, 124.3, 121.9, 28.6, 15.6,
14.1. HRMS calcd for C18H17NO+ [M+]: 263.1310, found 263.1322.
2-Methyl-5-(2-methylphenyl)oxazole (3j).11a Light yellow oil (31.7
mg, 61%). IR (neat): 2927, 1648, 1585, 1557, 1142, 1092, 762 cm−1.
1H NMR (400 MHz, CDCl3): δ 7.69−7.63 (m, 1H), 7.30−7.22 (m,
3H), 7.10 (s, 1H), 2.54 (s, 3H), 2.46 (s, 3H). 13C NMR (100 MHz,
CDCl3): δ 160.7, 150.5, 134.7, 131.1, 128.1, 127.5, 126.6, 126.1, 124.8,
21.8, 14.0.
General Procedure for the Heterogeneous Gold-Catalyzed
Oxazole Formation. 8-Methylquinoline N-oxide (E, 62 mg, 0.39
mmol) and MCM-41−PPh3−AuNTf2 (60 mg, 0.015 mmol) were
added to a solution of a terminal alkyne 1 (0.3 mmol) in nitrile 2 (3
mL) at 60 °C. The reaction mixture was stirred at 60 °C for 8−24 h.
After being cooled to room temperature, the catalyst was separated by
a simple filtration of the reaction solution, washed with ethyl acetate (2
× 5 mL) and diethyl ether (2 × 5 mL), and reused in the next run.
The filtrate was concentrated under reduced pressure, and the residue
was purified by chromatography on silica gel (eluent: light petroleum
ether/ethyl acetate = 5:1) to afford the oxazole product 3.
2-Methyl-5-phenyloxazole (3a).27 Light yellow solid (43.4 mg,
91%). Mp 58−59 °C. IR (KBr): 2925, 1696, 1558, 1451, 942, 766, 690
cm−1. 1H NMR (400 MHz, CDCl3): δ 7.64−7.57 (m, 2H), 7.40 (t, J =
7.6 Hz, 2H), 7.30 (t, J = 7.4 Hz, 1H), 7.20 (s, 1H), 2.53 (s, 3H). 13C
NMR (100 MHz, CDCl3): δ 161.0, 151.1, 128.8, 128.2, 128.1, 123.9,
121.9, 14.1.
5-(2-Chlorophenyl)-2-methyloxazole (3k). Brown oil (36.6 mg,
1
63%). IR (neat): 2924, 1645, 1575, 1448, 1061, 934, 760 cm−1. H
NMR (400 MHz, CDCl3): δ 7.77 (dd, J = 8.0, 1.6 Hz, 1H), 7.64 (s,
1H), 7.47−7.44 (m, 1H), 7.36−7.30 (m, 1H), 7.26−7.20 (m, 1H),
2.54 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 161.0, 147.7, 134.3,
130.6, 130.4, 128.6, 127.5, 127.1, 127.0, 14.0. HRMS calcd for
C10H8ClNO+ [M+]: 193.0294, found 193.0296.
2-Methyl-5-(naphthalen-1-yl)oxazole (3l). Red brown oil (45.2
mg, 72%). IR (neat): 2923, 1639, 1592, 1578, 1345, 1083, 825, 746
cm−1. 1H NMR (400 MHz, CDCl3): δ 8.26 (d, J = 8.0 Hz, 1H), 7.90−
7.83 (m, 2H), 7.70 (d, J = 7.6 Hz, 1H), 7.57−7.47 (m, 3H), 7.29 (s,
1H), 2.59 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 161.3, 150.2,
133.9, 130.1, 129.3, 128.7, 126.9, 126.2, 126.1, 125.6, 125.3, 125.2,
124.9, 14.1. HRMS calcd for C14H11NO+ [M+]: 209.0841, found
209.0840.
2-Methyl-5-(4-methylphenyl)oxazole (3b).27 Light yellow solid
(46.2 mg, 89%). Mp 57−58 °C. IR (KBr): 2923, 1646, 1596, 1554,
1060, 956, 824, 817 cm−1. 1H NMR (400 MHz, CDCl3): δ 7.49 (d, J =
8.0 Hz, 2H), 7.20 (d, J = 8.0 Hz, 2H), 7.14 (s, 1H), 2.51 (s, 3H), 2.37
(s, 3H). 13C NMR (100 MHz, CDCl3): δ 160.6, 151.3, 138.1, 129.5,
125.5, 123.9, 121.2, 21.3, 14.0.
5-(4-Ethynylphenyl)-2-methyloxazole (3m). Light yellow solid
(40.7 mg, 74%). Mp 119−120 °C. IR (KBr): 3291, 2926, 2127,
1
1593, 1578, 1059, 949, 743 cm−1. H NMR (400 MHz, CDCl3): δ
5-(4-Butylphenyl)-2-methyloxazole (3c). Light yellow oil (55.5 mg,
1
86%). IR (neat): 2927, 1651, 1597, 1548, 1063, 954, 826 cm−1. H
7.57−7.54 (m, 2H), 7.53−7.50 (m, 2H), 7.23 (s, 1H), 3.14 (s, 1H),
2.53 (s, 3H). 13C NMR (100 MHz, CDCl3): δ 161.5, 150.4, 132.6,
128.4, 123.7, 122.9, 121.7, 83.3, 78.3, 14.1. HRMS calcd for C12H9NO+
[M+]: 183.0684, found 183.0678.
NMR (400 MHz, CDCl3): δ 7.50 (d, J = 8.4 Hz, 2H), 7.20 (d, J = 8.4
Hz, 2H), 7.14 (s, 1H), 2.61 (t, J = 7.8 Hz, 2H), 2.50 (s, 3H), 1.65−
1.55 (m, 2H), 1.41−1.30 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H). 13C NMR
(100 MHz, CDCl3): δ 160.7, 151.4, 143.1, 128.9, 125.7, 123.9, 121.2,
35.4, 33.5, 22.3, 14.0, 13.9. HRMS calcd for C14H17NO+ [M+]:
215.1310, found 215.1314.
5-Butyl-2-methyloxazole (3n). Light yellow oil (29.6 mg, 71%). IR
(neat): 2954, 1579, 1445, 1222, 1118, 750 cm−1. 1H NMR (400 MHz,
CDCl3): δ 6.57 (s, 1H), 2.59 (t, J = 7.6 Hz, 2H), 2.40 (s, 3H), 1.64−
1.56 (m, 2H), 1.41−1.32 (m, 2H), 0.93 (t, J = 7.4 Hz, 3H). 13C NMR
(100 MHz, CDCl3): δ 160.1, 152.7, 121.8, 29.7, 25.2, 22.1, 13.9, 13.7.
HRMS calcd for C8H13NO+ [M+]: 139.0997, found 139.0989.
5-(3-Chloropropyl)-2-methyloxazole (3o). Light yellow oil (39.3
5-(4-Methoxyphenyl)-2-methyloxazole (3d).27 Light yellow solid
(52.2 mg, 92%). Mp 89−90 °C. IR (KBr): 2962, 2837, 1585, 1506,
1028, 832, 814, 750 cm−1. 1H NMR (400 MHz, CDCl3): δ 7.51 (d, J =
8.8 Hz, 2H), 7.06 (s, 1H), 6.92 (d, J = 8.8 Hz, 2H), 3.82 (s, 3H), 2.49
(s, 3H). 13C NMR (100 MHz, CDCl3): δ 160.3, 159.6, 151.1, 125.5,
121.1, 120.3, 114.3, 55.3, 14.0.
1
mg, 82%). IR (neat): 2956, 1578, 1446, 1223, 1120, 749 cm−1. H
NMR (400 MHz, CDCl3): δ 6.65 (s, 1H), 3.57 (t, J = 6.4 Hz, 2H),
2.79 (t, J = 7.2 Hz, 2H), 2.41 (s, 3H), 2.13−2.03 (m, 2H). 13C NMR
(100 MHz, CDCl3): δ 160.6, 150.7, 122.8, 43.7, 30.5, 22.7, 13.9.
C7H10ClNO+ [M+]: 159.0451, found 159.0455.
2-Methyl-5-(3-methylphenyl)oxazole (3e).27 Light yellow oil (42.6
mg, 82%). IR (neat): 2925, 1643, 1587, 1546, 1083, 946, 816, 760
cm−1. 1H NMR (400 MHz, CDCl3): δ 7.45−7.38 (m, 2H), 7.32−7.26
(m, 1H), 7.18 (s, 1H), 7.12 (d, J = 7.6 Hz, 1H), 2.52 (s, 3H), 2.39 (s,
3H). 13C NMR (100 MHz, CDCl3): δ 160.9, 151.3, 138.5, 128.9,
128.8, 128.1, 124.6, 121.8, 121.1, 21.4, 14.0.
2-Methyl-5-(3-phenylpropyl)oxazole (3p). Light yellow oil (53.1
mg, 88%). IR (neat): 2926, 1693, 1577, 1447, 1364, 1121, 751, 698
cm−1. 1H NMR (400 MHz, CDCl3): δ 7.31−7.26 (m, 2H), 7.22−7.14
(m, 3H), 6.59 (s, 1H), 2.67 (t, J = 7.6 Hz, 2H), 2.61 (t, J = 7.4 Hz,
2H), 2.40 (s, 3H), 2.00−1.91 (m, 2H). 13C NMR (100 MHz, CDCl3):
δ 160.2, 152.2, 141.5, 128.5, 128.4, 126.0, 122.2, 35.1, 29.2, 24.9, 13.9.
HRMS calcd for C13H15NO+ [M+]: 201.1154, found 201.1159.
5-Cyclopropyl-2-methyloxazole (3q). Light yellow oil (28.1 mg,
5-(4-Chlorophenyl)-2-methyloxazole (3f).27 Light yellow solid
(43.0 mg, 74%). Mp 84−85 °C. IR (KBr): 2924, 1641, 1599, 1442,
1
1059, 941, 812 cm−1. H NMR (400 MHz, CDCl3): δ 7.56−7.51 (m,
2H), 7.41−7.34 (m, 2H), 7.19 (s, 1H), 2.52 (s, 3H). 13C NMR (100
MHz, CDCl3): δ 161.3, 150.2, 133.9, 129.1, 126.7, 125.2, 122.3, 14.0.
5-(4-Bromophenyl)-2-methyloxazole (3g).27 Light yellow solid
(52.1 mg, 73%). Mp 82−83 °C. IR (KBr): 2922, 1664, 1574, 1550,
1360, 1077, 948, 817 cm−1. 1H NMR (400 MHz, CDCl3): δ 7.53 (d, J
= 8.8 Hz, 2H), 7.47 (d, J = 8.8 Hz, 2H), 7.21 (s, 1H), 2.52 (s, 3H). 13C
NMR (100 MHz, CDCl3): δ 161.3, 150.2, 132.0, 127.1, 125.4, 122.4,
121.9, 14.1.
1
76%). IR (neat): 2972, 2359, 1614, 1569, 976, 750 cm−1. H NMR
(400 MHz, CDCl3): δ 6.55 (s, 1H), 2.38 (s, 3H), 1.86−1.79 (m, 1H),
0.91−0.76 (m, 4H). 13C NMR (100 MHz, CDCl3): δ 159.7, 149.7,
121.0, 14.2, 13.9, 6.2. HRMS calcd for C7H9NO+ [M+]: 123.0684,
found 123.0691.
5-Cyclohexyl-2-methyloxazole (3r).11a Light yellow oil (41.6 mg,
1
84%). IR (neat): 2930, 2361, 1579, 1450, 1219, 754 cm−1. H NMR
5-(3-Chloro-4-methylphenyl)-2-methyloxazole (3h). Light yellow
oil (48.6 mg, 78%). IR (neat): 2923, 1639, 1579, 1472, 1063, 931, 822
cm−1. 1H NMR (400 MHz, CDCl3): δ 7.59 (d, J = 1.6 Hz, 1H), 7.40−
7.35 (m, 1H), 7.24 (d, J = 8.0 Hz, 1H), 7.17 (s, 1H), 2.52 (s, 3H), 2.39
(s, 3H). 13C NMR (100 MHz, CDCl3): δ 161.2, 150.0, 135.9, 135.0,
131.4, 127.4, 124.5, 122.2, 122.1, 19.9, 14.1. HRMS calcd for
C11H10ClNO+ [M+]: 207.0451, found 207.0446.
5-(4′-Ethylbiphenyl-4-yl)-2-methyloxazole (3i). White solid (66.4
mg, 84%). Mp 160−162 °C. IR (KBr): 2926, 1661, 1594, 1548, 1365,
1059, 942, 821 cm−1. 1H NMR (400 MHz, CDCl3): δ 7.65 (d, J = 8.8
Hz, 2H), 7.61 (d, J = 8.8 Hz, 2H), 7.53 (d, J = 8.0 Hz, 2H), 7.28 (d, J
= 8.4 Hz, 2H), 7.22 (s, 1H), 2.69 (q, J = 7.6 Hz, 2H), 2.53 (s, 3H),
1.27 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3): δ 161.1, 151.0,
(400 MHz, CDCl3): δ 6.54 (s, 1H), 2.65−2.54 (m, 1H), 2.39 (s, 3H),
2.02−1.95 (m, 2H), 1.81−1.67 (m, 3H), 1.42−1.29 (m, 5H). 13C
NMR (100 MHz, CDCl3): δ 159.8, 157.1, 120.2, 35.2, 31.1, 26.0, 25.7,
13.9.
5-(2-Methyloxazol-5-yl)pentanoic Acid (3s).11a Light yellow solid
(45.6 mg, 83%). Mp 76−77 °C. IR (KBr): 3115, 2942, 2358, 1696,
1262, 751 cm−1. 1H NMR (400 MHz, CDCl3): δ 10.06 (br, 1H), 6.64
(s, 1H), 2.66−2.58 (m, 2H), 2.42 (s, 3H), 2.41−2.35 (m, 2H), 1.75−
1.66 (m, 4H). 13C NMR (100 MHz, CDCl3): δ 177.6, 160.6, 152.2,
121.4, 33.8, 27.0, 25.2, 24.2, 13.7.
2-Methyl-5-[2-(tetrahydropyran-2-yloxy)ethyl]oxazole (3t).11a
Red brown oil (50.7 mg, 80%). IR (neat): 2942, 2873, 1579, 1384,
1
1123, 1035 cm−1. H NMR (400 MHz, CDCl3): δ 6.68 (s, 1H), 4.62
F
J. Org. Chem. XXXX, XXX, XXX−XXX